Report Content
- Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
- Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
- Executive Summary
- Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
- Fiducial Markers Market, By Product
5.1 Introduction
5.2 Metal-based Markers
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Polymer-based Markers
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Other Fiducial Markers
5.4.1 Market Overview
5.4.2 Market Size and Forecast
- Fiducial Markers Market, By Modality
6.1 Introduction
6.2 CT/CBCT
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 MRI
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Ultrasound
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Radiotherapy
6.5.1 Market Overview
6.5.2 Market Size and Forecast
- Fiducial Markers Market, By Cancer Type
7.1 Introduction
7.2 Prostate Cancer
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Lung Cancer
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Breast Cancer
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Gastric Cancer
7.5.1 Market Overview
7.5.2 Market Size and Forecast
7.6 Other Cancers
7.6.1 Market Overview
7.6.2 Market Size and Forecast
- Fiducial Markers Market, By End User
8.1 Introduction
8.2 Hospitals & Outpatient Facilities
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Independent Radiotherapy Centers
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Cancer Research Centers
8.4.1 Market Overview
8.4.2 Market Size and Forecast
- Fiducial Markers Market, By Geography
9.1 Introduction
9.2 Europe
9.2.1 Europe Fiducial Markers, By Product
9.2.2 Europe Fiducial Markers, By Modality
9.2.3 Europe Fiducial Markers, By Cancer Type
9.2.4 Europe Fiducial Markers, By End User
9.3 North America
9.3.1 North America Fiducial Markers, By Product
9.3.2 North America Fiducial Markers, By Modality
9.3.3 North America Fiducial Markers, By Cancer Type
9.3.4 North America Fiducial Markers, By End User
9.4 Asia Pacific
9.4.1 Asia Pacific Fiducial Markers, By Product
9.4.2 Asia Pacific Fiducial Markers, By Modality
9.4.3 Asia Pacific Fiducial Markers, By Cancer Type
9.4.4 Asia Pacific Fiducial Markers, By End User
9.5 Rest of The World
9.5.1 Rest of The World Fiducial Markers, By Product
9.5.2 Rest of The World Fiducial Markers, By Modality
9.5.3 Rest of The World Fiducial Markers, By Cancer Type
9.5.4 Rest of The World Fiducial Markers, By End User
- Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
- Company Profiles
(Overview, Key Financials, Recent Developments, Product and Service Offering)
- CIVCO Radiotherapy
- Boston Scientific Corporation
- IZI Medical Products
- IBA
- Naslund Medical AB
- Medtronic
- Best Medical International, Inc.
- Nanovi A/S
- Carbon Medical Technologies
- Eckert & Ziegler
- Innovative Oncology Solutions
- QlRad Inc.
- Stellar Medical
- JJ-Medtech
- QFIX
- Other Companies